LONDON--(EON: Enhanced Online News)--IMS Health and the Life Sciences division of BroadReach Healthcare today announced a strategic alliance to deliver comprehensive advisory and commercial effectiveness solutions for life sciences organizations operating in Africa. The alliance brings together IMS Health’s industry-leading information, analytics, consulting and technology capabilities with BroadReach Healthcare’s deep knowledge of the African healthcare landscape and local regulatory environment. Life sciences organizations will gain immediate access to information and services that support market assessment, market entry planning and commercial implementation across the continent.
“Africa represents a significant growth opportunity for life sciences companies. At the same time, healthcare organizations need to be aware of the challenges in developing viable market strategies in this fast-evolving region”
IMS Health is actively engaged with governments, NGOs and private sector stakeholders to support evidence-based decision making and advance healthcare in the region. Since 2003, BroadReach Healthcare has worked closely with aid agencies, regulatory authorities, governments, and leading pharmaceutical and medical device companies to drive the design, planning and delivery of healthcare programs, with a focus on sub-Saharan Africa. The two organizations have worked together on several joint initiatives, which include helping clients in the areas of strategic planning, pricing and market access, and healthcare implementation.
“Africa represents a significant growth opportunity for life sciences companies. At the same time, healthcare organizations need to be aware of the challenges in developing viable market strategies in this fast-evolving region,” said Alistair Grenfell, who oversees IMS Health’s business in Africa. “Our global healthcare expertise uniquely positions us to help clients unlock this opportunity and support stakeholder decisions in a range of areas — from access to medicines and care, to market measurement and investment decisions. Our alliance with BroadReach Healthcare strengthens our ability to apply innovative on-the-ground approaches based on local market experience and perspectives.”
IMS Health and BroadReach Healthcare will offer life sciences companies:
- Advisory services to size, select and prioritize markets, develop pricing, and plan market entry and manufacturing/distribution strategies
- Comprehensive regulatory support, from strategy development to post-approval compliance, provided by locally based specialists
- Program implementation and management services to improve healthcare access and patient education in individual markets
The combination of economic growth and a rising middle class in Africa is driving increased investment in health system infrastructure, capacity building, treatment provision and specialized health services. Pharmaceutical spending in Africa is expected to reach $45 billion by 2020.
Said Dr. John Sargent, founding partner of BroadReach Healthcare, “Over the past decade, we have brought together leaders in all sectors — public, private, non-profit and non-traditional players — to implement disease prevention and management programs across the continent. That includes establishing partnerships with foundations, public/private alliances and government agencies that have an interest in African markets and their development. Together with IMS Health, we will ensure that our accumulated knowledge and extensive capabilities help to unlock the potential of the African marketplace and improve healthcare for millions on the continent.”
About BroadReach Healthcare
BroadReach Healthcare is a global healthcare solutions firm founded with the mission of improving access to and the quality of healthcare to patients in emerging markets by utilizing private sector approaches to develop sustainable solutions. Services include strategic consulting, data and informatics, regulatory affairs, disease management, large scale program implementation & management, patient education and adherence support programs, and healthcare worker training programs. BroadReach carries this work out in two, inter-related businesses — Global Health and Life Sciences — serving governments, donors, NGOs, pharmaceutical and medical device companies across all key emerging markets with a focus on sub-Saharan Africa. Additional information is available at www.broadreachhealthcare.com.
About IMS Health
IMS Health is a leading worldwide provider of information, technology and services dedicated to making healthcare perform better. With a global technology infrastructure and unique combination of real-world evidence, advanced analytics and proprietary software platforms, IMS Health connects knowledge across all aspects of healthcare to help clients improve patient outcomes and operate more efficiently. The company’s expert resources draw on data from nearly 100,000 suppliers, and on insights from more than 40 billion healthcare transactions processed annually, to serve more than 5,000 healthcare clients globally. Customers include pharmaceutical, medical device and consumer health manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.